Victory Capital Management Inc. Boosts Stake in Agilent Technologies, Inc. $A

Key Points

• Victory Capital Management increased its stake in Agilent by 5.0% to 248,708 shares, worth about $31.92M and representing roughly 0.09% of the company.
• Agilent missed quarterly estimates narrowly with $1.36 EPS and $1.80B revenue (+7% YoY), and set FY2026 guidance of EPS 5.900–6.040 and Q2 guidance of 1.390–1.420.
• Several analysts have cut price targets (UBS, TD Cowen, Wells Fargo) while others initiated or maintained buys (HSBC, Goldman), leaving a consensus rating of "Moderate Buy" with an average target of $161.20.

Victory Capital Management Inc. increased its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 5.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 248,708 shares of the medical research company's stock after acquiring an additional 11,799 shares during the period. Victory Capital Management Inc. owned approximately 0.09% of Agilent Technologies worth $31,922,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Brighton Jones LLC raised its stake in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after buying an additional 270 shares during the period. Jones Financial Companies Lllp grew its stake in Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after acquiring an additional 769 shares during the period. Geneos Wealth Management Inc. increased its holdings in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock worth $70,000 after acquiring an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its position in Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock worth $625,000 after acquiring an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in Agilent Technologies during the second quarter worth $273,000. Institutional investors and hedge funds own 87.41% of the company's stock.

Analysts Set New Price Targets

A has been the topic of several research analyst reports. UBS Group dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a research report on Thursday, February 26th. TD Cowen lowered their price objective on Agilent Technologies from $170.00 to $157.00 and set a "buy" rating on the stock in a report on Thursday, February 26th. HSBC began coverage on Agilent Technologies in a report on Tuesday, January 20th. They set a "buy" rating and a $180.00 target price for the company. The Goldman Sachs Group assumed coverage on Agilent Technologies in a research note on Tuesday, December 9th. They issued a "buy" rating and a $170.00 price target on the stock. Finally, Wells Fargo & Company dropped their price target on Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating for the company in a research report on Thursday, February 26th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $161.20.

Agilent Technologies Price Performance

NYSE:A opened at $115.11 on Monday. The stock has a 50 day moving average price of $132.65 and a 200 day moving average price of $136.12. The stock has a market cap of $32.53 billion, a PE ratio of 25.41, a P/E/G ratio of 2.42 and a beta of 1.31. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company had revenue of $1.80 billion during the quarter, compared to analysts' expectations of $1.81 billion. During the same quarter in the previous year, the company earned $1.31 earnings per share. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies's payout ratio is presently 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.